These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1863406)

  • 21. Hepatitis B Virus infection in HIV-positive population in Brazil: results of a survey in the state of Mato Grosso and a comparative analysis with other regions of Brazil.
    de Almeida Pereira RA; Mussi AD; de Azevedo e Silva VC; Souto FJ
    BMC Infect Dis; 2006 Feb; 6():34. PubMed ID: 16504137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV infection and risk behaviour of commercial sex workers and intravenous drug users in Slovakia.
    Staneková D; Jiresová K; Habeková M; Wimmerová S; Cuitti M; Vavrincíková L; Valachovicová M; Kovacic V; Mayer V
    Cent Eur J Public Health; 2004 Dec; 12(4):197-200. PubMed ID: 15666457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations.
    Kemp R; Miller J; Lungley S; Baker M
    N Z Med J; 1998 Feb; 111(1060):50-3. PubMed ID: 9539916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.
    Long J; Allwright S; Barry J; Reynolds SR; Thornton L; Bradley F; Parry JV
    BMJ; 2001 Nov; 323(7323):1209-13. PubMed ID: 11719410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey.
    Allwright S; Bradley F; Long J; Barry J; Thornton L; Parry JV
    BMJ; 2000 Jul; 321(7253):78-82. PubMed ID: 10884256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
    Gupta S; Singh S
    BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
    Kolovrat A; Jurisić I; Marić Z; Cvitković A
    Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.
    Gilson RJ; de Ruiter A; Waite J; Ross E; Loveday C; Howell DR; Tedder RS; Weller IV
    Sex Transm Infect; 1998 Apr; 74(2):110-5. PubMed ID: 9634322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India.
    Singh S; Prasad R; Mohanty A
    Int J STD AIDS; 1999 Jul; 10(7):475-8. PubMed ID: 10454185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection in injecting drug users attending centres in England and Wales, 1990-1991.
    Noone A; Durante AJ; Brady AR; Majid F; Swan AV; Parry JV; Hart GJ; Connell JA; Perry KR; Joce RE
    AIDS; 1993 Nov; 7(11):1501-7. PubMed ID: 8280418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
    Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
    Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals.
    Flores GL; de Almeida AJ; Miguel JC; Cruz HM; Portilho MM; Scalioni Lde P; Marques VA; Lewis-Ximenez LL; Lampe E; Villar LM
    Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26978383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco.
    Hahn JA; Page-Shafer K; Lum PJ; Ochoa K; Moss AR
    Hepatology; 2001 Jul; 34(1):180-7. PubMed ID: 11431749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spread of bloodborne viruses among Australian prison entrants.
    Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
    BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Voluntary HIV testing in Iceland. Infection risk factors and prevalence of antibodies against HIV, hepatitis B and C viruses].
    Snorrason GJ; Sigurthsson S; Gudmundsson S; Briem H
    Nord Med; 1993; 108(3):76-7, 89. PubMed ID: 7681163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.